Table 2.
Statistical summary of comorbidity incidence rates.
| Severity Comorbidities a | Whole Sample | Mild | Moderate | Severe | Very Severe | Population Incidence b (%) |
|---|---|---|---|---|---|---|
| Observation | 142 | 40 | 53 | 30 | 19 | |
| (%) | ||||||
| Rhinitis | 4.46 | 10.00 | 4.87 | 0.00 | 0.00 | 15–20 [40] |
| Diabetes | 12.5 | 16.67 | 9.75 | 15.38 | 7.14 | 12.8 [41] |
| Hypertension | 31.25 | 30.00 | 26.82 | 38.46 | 35.71 | 23.30 [42] |
| Cardiovascular | 19.51 | 7.88 | 43.47 | 61.54 | 64.28 | 6.8 [42] |
| Renal | 0.61 | 0.00 | 4.34 | 0.00 | 0.00 | 2.9 [42] |
| Liver | 1.22 | 0.83 | 2.17 | 0.00 | 7.14 | 6.1 [42] |
| GI | 2.74 | 0.83 | 0.00 | 15.38 | 21.43 | 6.6 [42] |
| Blood Abnormal | 0.30 | 0.00 | 2.17 | 0.00 | 0.00 | |
| Neurological | 0.61 | 0.04 | 2.17 | 0.00 | 0.00 | |
| Metabolism | 5.79 | 1.66 | 15.21 | 23.07 | 14.28 | 10–15 [43] |
| Cancer | 8.93 | 3.33 | 9.75 | 15.38 | 7.14 | 0.38 [44] |
Note: a The comorbidity records were self-reported; therefore, only general classifications of comorbidities were provided. b Selected comorbidity incidence rates based on the availability for the general population in Taiwan are presented in the last column for comparison purposes.